SAVA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Cassava Sciences Inc

NASDAQ | SAVA

3.91

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 23, 2025)

$178.74M

Market Cap

-

P/E Ratio

-2.63

EPS

$33.97

52 Week High

$1.14

52 Week Low

HEALTHCARE

Sector

SAVA Chart

Recent Chart
Price Action

SAVA Technicals

Tags:

SAVA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$151M
Selling General And Administrative $72M
Research And Development $70M
Operating Expenses $150M
Investment Income Net -
Net Interest Income $8.5M
Interest Income $8.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$24M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$24M
Comprehensive Income Net Of Tax -
Ebit -$24M
Ebitda -$23M
Net Income -$24M

Revenue & Profitability

Earnings Performance

SAVA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $158M
Total Current Assets $137M
Cash And Cash Equivalents At Carrying Value $129M
Cash And Short Term Investments $129M
Inventory -
Current Net Receivables $947K
Total Non Current Assets $21M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $37K
Intangible Assets Excluding Goodwill $37K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $7M
Other Non Current Assets -
Total Liabilities $12M
Total Current Liabilities $12M
Current Accounts Payable $7.7M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $79K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $4.1M
Other Non Current Liabilities $79K
Total Shareholder Equity $146M
Treasury Stock -
Retained Earnings -$405M
Common Stock $48K
Common Stock Shares Outstanding $47M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$117M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $103K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$103K
Cashflow From Financing $124M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$24M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$151M
Selling General And Administrative $72M
Research And Development $70M
Operating Expenses $150M
Investment Income Net -
Net Interest Income $8.5M
Interest Income $8.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$24M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$24M
Comprehensive Income Net Of Tax -
Ebit -$24M
Ebitda -$23M
Net Income -$24M

Dividends

Field Value
Ex Dividend Date 2012-12-13
Declaration Date None
Record Date None
Payment Date None
Amount 0.75

SAVA News

SAVA Profile

Cassava Sciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas, dedicated to pioneering innovative therapies for neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company is advancing its lead candidate, simufilam, through late-stage clinical trials to establish its potential effectiveness and safety. By addressing critical unmet medical needs in neurology, Cassava aims to transform the treatment landscape for neurodegenerative disorders, positioning itself as a significant player in enhancing patient outcomes and quality of life.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.